Wednesday, October 4, 2023
Wednesday, October 4, 2023

Contact: 561.316.3330

GSA Supports Rapid Deployment of Xenex LightStrike Germ-Zapping Robots to Federal Agencies with Contract Renewal

Xenex Disinfection Services, the world leader in UV disinfection technology for healthcare facilities, today announced the 5-year renewal of its U.S. General Services Administration (GSA) contract, which enables federal agencies (including Veterans Affairs and U.S. Department of Defense healthcare facilities) to easily deploy Xenex’s powerful LightStrike™ room disinfection technology.

In addition to federal agencies, the GSA contract supports the procurement needs of eligible state, local, territorial, and tribal governments (including schools). The GSA Schedule program is the premier acquisition vehicle for the U.S. government, providing an easy and efficient way for government buyers to connect with commercial companies.

LightStrike Germ-Zapping Robots™, which first became available via GSA contract in 2012, provide a fast and effective way to disinfect healthcare facilities. More than 130 government healthcare facilities including VA, Army, Navy, Air Force, and Marine Corps hospitals use Xenex LightStrike robots for daily room disinfection. In 2012, the W. G. (Bill) Hefner VA Medical Center in Salisbury, NC was the first VA hospital to deploy four LightStrike robots and today, utilizes its 11 LightStrike robots to disinfect ORs, ICUs, patient rooms, the Emergency Department, catheterization lab, oncology, dialysis, public restrooms and much more.

Why is disinfection necessary?

Studies show that less than half the surfaces in a patient room are disinfected when it’s being cleaned and prepared for the next patient. Pathogens such as Clostridium difficile (C.diff), methicillin-resistant Staphylococcus aureus (MRSA), Acinetobacter, and Candida auris that may be left behind on high touch surfaces can transmit from patient to patient or patient to healthcare worker. Some deadly superbugs are showing resistance to cleaning chemicals, making the pathogens even more difficult to remove.

The LightStrike robot utilizes intense bursts of pulsed xenon ultraviolet (UV) light to quickly deactivate viruses, bacteria and spores on surfaces and is effective against even the most dangerous superbugs and multi-drug resistant organisms, including MRSA, C.diff, and SARS-CoV-2 (the virus that causes COVID-19). Additionally, the LightStrike robot has been proven effective against both the Ebola virus and Anthrax and can easily be incorporated into a facility’s biodefense strategy.

“There’s never been a more important time to have a disinfected environment. Viruses and bacteria are becoming resistant to chemicals, antibiotics and even some hand sanitizers. We are honored to be part of the disinfection strategy for the VA and DOD hospitals using LightStrike robots for room disinfection. Protecting the environment for those who protect us every day is an honor and we are committed to helping our government customers every step of the way,” said Joe Monroe, vice president of U.S. sales for Xenex.


More than 45 peer-reviewed studies have been published validating the efficacy of LightStrike technology. The Central Texas Veterans Health Care System is a pioneer in the utilization of UV technology for room disinfection and has conducted numerous studies about LightStrike pulsed xenon UV robots. One study published in the American Journal of Infection Control indicates that pulsed xenon-based ultraviolet light systems effectively reduce aerobic bacteria in the absence of manual disinfection.

Environmental Protection for Government Facilities

Xenex robots are designed and manufactured in the U.S. and use pulsed xenon lamps (not mercury bulbs) to generate broad spectrum UV light. The robots don’t require warm-up or cool-down time, and don’t harm surfaces or expensive hospital equipment like mercury lamp UV products. In 2009, the U.S. Department of Energy issued an Executive Order for federal agencies to become more protective of the environment in practices including the use of non-toxic or less toxic alternatives when possible where these products meet the performance requirements of the agency.

LightStrike robots are also available via Geo-Med, LLC, a Service-Disabled Veteran-Owned Small Business (SDVOSB). GeoMed provides a broad range of medical and surgical products to Veterans Health Administration medical centers and DOD military treatment facilities via its GSA Contract and ECAT Capital Equipment Contract.

Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Centinel Spine’s prodisc ® Continues to Change Lives After Over 30 Years and 250,000 Total Disc Replacement Implantations

The prodisc lumbar and cervical technologies will be highlighted by Centinel Spine at the upcoming 2023 annual EUROSPINE meeting and congress in Frankfurt, Germany (October 4-6, 2023). The prodisc technology portfolio now includes four cervical and two lumbar devices—5 approved by the FDA—and has been validated with a reported reoperation rate of less than 1%.

Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System

This first-in-human clinical trial will assess the safety and effectiveness of the VCFix® Spinal System implant for patients suffering from vertebral compression fractures. The implant is provided with a user-friendly, single-use sterile surgical kit, ensuring perfect traceability and reducing the risk of infection. 

RaySearch Deepens Collaboration with P-Cure

The expanded collaboration will enable users of the P-Cure proton therapy system to use RayStation and RayCare in a seamlessly integrated environment. The P-Cure system is a gantry-less seated proton system, designed to fit within linac vaults, that has recently been cleared by the FDA. It is used clinically by the Hadassah Medical Center in Jerusalem – the only proton facility in the Middle East – to treat CNS, head and neck, thoracic and pancreatic malignancies.

Edinburgh-based Med-tech Firm in MBO to Expand Into New Markets and Technologies

The acquisition will enable Novarum to build on its strong lateral flow test customer base and extend into adjacent markets. 

Biomic Sciences Issues Voluntary Nationwide Recall of ION* Sinus Support, ION* Biome Sinus, and Restore Sinus Spray Products Due to Microbial Contamination

Risk Statement: In the population most at risk, patients or individuals who recently underwent nasal or sinus surgery, there is a reasonable probability that the use of the affected product could potentially result in severe or life-threatening adverse events such as bacteremia or fungemia, invasive bacterial or fungal rhinosinusitis, or disseminated fungal infection. To date, Biomic Sciences has not received any reports of adverse events related to this product.

By using this website you agree to accept Medical Device News Magazine Privacy Policy